Investigación de fármacos cardiovasculares

Principales actores: Amgen, Novartis, Boehringer Ingelheim, Pfizer, Baxter

Principales actores: Medtronic, Boston Scientific, Abbott Laboratories, Teva Pharmaceutical Industries, Sun Pharmaceuticals Industries

Principales actores: Viatris, Teva Pharmaceutical Industries, Grupo Sandoz, Sun Pharmaceuticals Industries, Dr. Reddy's Laboratories

Principales actores: Pfizer, Alnylam Pharmaceuticals, Ionis Pharmaceuticals/AstraZeneca, BridgeBio Pharma (Eidos), Intellia Therapeutics

Principales actores: Boehringer Ingelheim, Bristol-Myers Squibb, Roche, Johnson & Johnson, Pfizer

Principales actores: AstraZeneca, Novartis, Pfizer, Bayer, Kowa

Principales actores: Mylan, Industrias farmacéuticas Teva, Pfizer, Sanofi y Laboratorios Upsher-Smith

Principales actores: Philips, Abbott Laboratories, Medtronic, Boston Scientific, Novartis

Principales actores: LimFlow, Sistemas Cardiovasculares, Eli Lilly and Company, Abbott Laboratories, Medtronic

Principales actores: Pfizer, Novartis, Sun Pharmaceuticals Industries, AstraZeneca, Merck

Principales actores: AstraZeneca, Bayer, Sanofi, Merck y Novartis

Principales actores: AstraZeneca, Pfizer, Novartis, Bristol Myers Squibb (incluido MyoKardia), Capricor Therapeutics

Principales actores: Amgen, Eli Lilly and Company, Gilead Sciences, GlaxoSmithKline, Bayer